Methylergonovine
Back to searchMolecule Structure
Scientific Name
Methylergonovine
Description of the Drug
Methylergometrine is an ergot alkaloid used to prevent and control uterine atony and hemorrhage before and after delivery.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00353
http://www.drugbank.ca/drugs/DB00353
Brand Name(s)
Not Available
Company Owner(s)
Tulex Pharmaceuticals Inc, Teva Pharmaceuticals Usa Inc, American Regent Inc, Novel Laboratories Inc, Edison Therapeutics Llc, Granules Pharmaceuticals Inc, Amneal Pharmaceuticals Of New York Llc, Breckenridge Pharmaceutical Inc, Rising Pharma Holdings Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dopamine D1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL2056 |
| Serotonin 2b (5-HT2b) receptor | SINGLE PROTEIN | PARTIAL AGONIST | CHEMBL1833 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL78176 | ||
| PharmGKB | PA450461 | ||
| Human Metabolome Database | HMDB0014497 | ||
| DrugBank | DB00353 | ||
| PubChem: Thomson Pharma | 14777917 | ||
| PubChem | 8226 | ||
| NMRShiftDB | 60022165 | ||
| LINCS | LSM-2758 | ||
| Nikkaji | J5.132B | ||
| PDBe | H8D | ||
| BindingDB | 50330860 | ||
| EPA CompTox Dashboard | DTXSID1023283 | ||
| DrugCentral | 1764 | ||
| Metabolights | MTBLC92607 | ||
| ChemicalBook | CB0833158 | ||
| Guide to Pharmacology | 150 | ||
| rxnorm | METHERGINE | METHYLERGONOVINE MALEATE | METHYLERGONOVINE |
| ChEBI | 92607 | ||
| ZINC | ZINC000095619105 |
